Aura Biosciences, Inc.
AURA
$6.46
$0.162.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.29% | 1.69% | -6.38% | -22.77% | -3.47% |
| Total Depreciation and Amortization | -2.10% | -1.72% | 0.00% | -7.03% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.81% | 15.17% | 34.78% | 21.90% | -4.28% |
| Change in Net Operating Assets | -3.16% | 379.20% | 144.90% | -127.89% | 95.83% |
| Cash from Operations | 3.03% | 11.05% | 2.49% | -56.83% | 5.30% |
| Capital Expenditure | -15.38% | 79.14% | 37.46% | 12.32% | 35.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -319.69% | -33.28% | 0.02% | 193.20% | -49.77% |
| Cash from Investing | -320.35% | -32.99% | 0.40% | 200.28% | -50.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.62% | 48,357.29% | -82.32% | -24.16% | 762.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -93.76% | 72,742.71% | -82.32% | -24.16% | 762.65% |
| Foreign Exchange rate Adjustments | -255.56% | 142.86% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.51% | 958.33% | 3.93% | 234.66% | -222.97% |